Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol vs sufentanil for postoperative analgesia in lumbar spine surgery and bowel function recovery
ChiCTR2500113008Phase 4Not yet recruiting
- Sponsor
- Shunde Hospital of Guangzhou University of Chinese Medicine
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tapentadol in postoperative pain (2 arms), sponsored by Shunde Hospital of Guangzhou University of Chinese Medicine. Primary endpoint: time_to_first_postoperative_flatus. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
tapentadol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500113008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113008.